# Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

> **NCT00296855** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 261 (actual)

## Conditions studied

- Peripheral Vascular Diseases

## Interventions

- **DRUG:** Vasovist (BAY86-5283, MS-325)

## Key facts

- **NCT ID:** NCT00296855
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2010-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296855, "Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00296855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*